GE HealthCare Technologies (NASDAQ:GEHC) Issues FY 2025 Earnings Guidance

Key Points

• GE HealthCare Technologies has updated its FY 2025 earnings guidance, projecting an EPS of 4.430-4.630, surpassing the consensus estimate of 4.065.
• Analysts have issued mixed ratings and price targets for the company's stock, with Morgan Stanley lowering their target to $78.00 while Citigroup increased theirs to $89.00, resulting in an average rating of "Moderate Buy".
• The company also announced a quarterly dividend of $0.035, representing an annualized yield of 0.18%, alongside a stock repurchase program authorizing $1.00 billion in share buybacks.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) updated its FY 2025 earnings guidance on Wednesday. The company provided earnings per share (EPS) guidance of 4.430-4.630 for the period, compared to the consensus estimate of 4.065. The company issued revenue guidance of -.

Wall Street Analysts Forecast Growth

A number of brokerages recently weighed in on GEHC. Wall Street Zen raised shares of GE HealthCare Technologies from a "hold" rating to a "buy" rating in a research report on Saturday, May 31st. The Goldman Sachs Group reduced their target price on shares of GE HealthCare Technologies from $94.00 to $82.00 and set a "buy" rating for the company in a report on Thursday, May 1st. Piper Sandler reduced their target price on shares of GE HealthCare Technologies from $104.00 to $88.00 and set an "overweight" rating for the company in a report on Wednesday, April 23rd. UBS Group raised shares of GE HealthCare Technologies from a "sell" rating to a "neutral" rating and reduced their target price for the company from $74.00 to $73.00 in a report on Monday, May 5th. Finally, Evercore ISI cut their price target on shares of GE HealthCare Technologies from $96.00 to $85.00 and set an "outperform" rating for the company in a report on Thursday, May 1st. Three research analysts have rated the stock with a hold rating, nine have issued a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $88.55.

GE HealthCare Technologies Price Performance

GEHC traded down $0.32 on Thursday, hitting $71.32. 6,256,943 shares of the company were exchanged, compared to its average volume of 3,725,612. The business's fifty day moving average is $73.57 and its 200 day moving average is $76.79. The firm has a market capitalization of $32.66 billion, a P/E ratio of 14.61, a price-to-earnings-growth ratio of 2.43 and a beta of 1.14. GE HealthCare Technologies has a fifty-two week low of $57.65 and a fifty-two week high of $94.80. The company has a debt-to-equity ratio of 0.85, a quick ratio of 0.76 and a current ratio of 1.16.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last released its quarterly earnings results on Wednesday, July 30th. The company reported $1.06 EPS for the quarter, beating the consensus estimate of $0.91 by $0.15. The business had revenue of $5 billion for the quarter, compared to analyst estimates of $4.96 billion. GE HealthCare Technologies had a net margin of 11.22% and a return on equity of 23.93%. The company's quarterly revenue was up 3.5% on a year-over-year basis. During the same period in the prior year, the business earned $1.00 earnings per share. As a group, sell-side analysts anticipate that GE HealthCare Technologies will post 4.68 EPS for the current year.

GE HealthCare Technologies Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, August 15th. Investors of record on Friday, July 25th will be given a dividend of $0.035 per share. The ex-dividend date is Friday, July 25th. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. GE HealthCare Technologies's dividend payout ratio (DPR) is 2.95%.

GE HealthCare Technologies announced that its Board of Directors has initiated a share buyback program on Wednesday, April 30th that permits the company to buyback $1.00 billion in outstanding shares. This buyback authorization permits the company to reacquire up to 3.1% of its stock through open market purchases. Stock buyback programs are usually an indication that the company's board believes its shares are undervalued.

Institutional Trading of GE HealthCare Technologies

An institutional investor recently raised its position in GE HealthCare Technologies stock. Empowered Funds LLC grew its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 6.1% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 28,848 shares of the company's stock after acquiring an additional 1,665 shares during the period. Empowered Funds LLC's holdings in GE HealthCare Technologies were worth $2,328,000 as of its most recent SEC filing. 82.06% of the stock is owned by hedge funds and other institutional investors.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.